marcus evans north america conferences

8th Annual Pharmacovigilance, Drug Safety & Risk Management

Enabling Predictive Drug Safety through Automation to Advance Pharmacovigilance Practices

20-21 Sep 2018
Philadelphia 201 Hotel | Philadelphia, PA, United States of America

Why You Should Attend

8th Annual Pharmacovigilance, Drug Safety & Risk Management

The 8th Annual Pharmacovigilance, Drug Safety & Risk Management Conference will address emerging trends in risk management, reporting automation & other surveillance strategies. Participants will discuss the latest strategies & tactics in building a comprehensive enterprise wide PV framework.

To download the agenda, please click here.

Key Topics

  • Leverage Artificial Intelligence and Machine Learning to minimize errors and improve data processing
  • Automate PV practices to streamline risk assessment and data capture
  • Enable predictive drug safety through a proactive risk management approach
  • Ensure safety by improving reporting and monitoring of adverse drug events
  • Develop strategies for incorporating and enhancing pharmacovigilance in combination products
  • Previous Attendees Include

    Baxter Healthcare Corporation, Biogen Idec, Eli Lilly, Gilead Sciences, Halozyme Therapeutics, Ipsen Biopharmaceuticals, Merck, Sanofi, Shire Human Genetic Therapies, Takeda Pharmaceuticals USA, Novartis Pharmaceuticals Corporation, Cubist Pharmaceuticals, Inc., EMD Serono, Inc., Pfizer, Inc., Johnson and Johnson, Amgen, and many more!

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Partners

    Practical Insights From

    Alexandre Kiazand, M.D.
    Head Safety Science

    Katherine Roberts
    Vice President, Global Pharmacovigilance Operations & Systems Quality Management

    Elizabeth Allee
    Senior Director, Case Processing Center of Expertise

    Tanya Taft
    Vice President of Patient Safety
    Fresenius Medical Care North America

    Linda Lum
    Director, Global Pharmacovigilance & Epidemiology
    Bristol-Myers Squibb

    Tamala Mallett More
    Therapeutic Area Lead
    Sanofi Pasteur

    Deepa Venkataraman
    Senior Director, Section Head, Drug Safety & Pharmacovigilance Operations
    Pharmacyclics LLC, an Abbvie Company

    Richard Wolf
    Head of Global Clinical Safety & Pharmacovigilance (GCSP) Regions & Pv Operations
    CSL Behring

    Click Here For Full Agenda

    Voice of Our Customers
    • “I find the 2 day event to be packed full of information to proactively assist current regulatory and strategic challenges in Pharmacovigilance.” – Sanofi
    • “Excellent content and organization.” – AstraZeneca
    • ‘Very informative and interesting while stayed focused in PV/Risk Management. I’m very impressed with the knowledge of the speakers.” – Allergan
    • “I really enjoyed and took lots of information back with me. Had ongoing changes discussed and future topics which made two days very interesting.” – EMD Serono
    • “Great forum for drug safety/PV, epidemiology and regulatory colleagues to collaborate and learn in a very focused forum.” – Gilead Sciences
    Join the Discussion

    Follow on LinkedIn

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Deborah Sacal

    The NBC Tower, 9th Floor
    455 N Cityfront Plaza Drive
    Chicago, IL 60611

    Fax: 312.894.6347